Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Abbvie inc. crawled date : 2021 - 06 - 09 save search
Global Psychedelic Drugs Market Research Report 2021-2026: Focus on Gamma-hydroxybutyrate, MDMA, Ketamine, Psilocybin, Others
Published: 2021-06-09 (Crawled : 20:00) - prnewswire.com
JNJ | News | $147.885 -1.12% 1.5M
|
Health Technology
|
| O: 0.25%
H: 0.95%
C: 0.65%
ABBV | News | $168.635 -0.53% 440K
|
Health Technology
|
| O: 0.32%
H: 2.3%
C: 1.64%
CMPS | $8.195 -0.67% 130K
|
Health Technology
|
| O: 2.77%
H: 1.02%
C: -1.5%
drug research ketamine psilocybin
Kojin Therapeutics Launches with $60 Million Series A to Develop New Category of Drugs Based on Cell State Biology
Published: 2021-06-09 (Crawled : 12:00) - biospace.com/
ABBV | News | $168.635 -0.53% 440K
|
Health Technology
|
| O: 0.48%
H: 1.36%
C: 0.99%
drug
Caraway Therapeutics Establishes Collaboration with AbbVie to Develop Novel Small Molecule Therapeutics for Parkinson’s Disease and Other Related Disorders
Published: 2021-06-09 (Crawled : 11:00) - biospace.com/
ABBV | News | $168.635 -0.53% 440K
|
Health Technology
|
| O: 0.48%
H: 1.36%
C: 0.99%
disease collaboration parkinson
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-09 (Crawled : 10:51) - fda.gov
PFE | News 4 | $26.21 -0.42% 5M
|
Health Technology
|
| O: 0.39%
H: 2.15%
C: 2.08%
LLY | News | $733.27 -1.67% 470K
|
Health Technology
|
| O: 0.29%
H: 2.43%
C: 2.1%
BMY | $48.795 -0.4% 1.5M
|
Health Technology
|
| O: 0.5%
H: 2.39%
C: 2.16%
ABBV | News | $168.635 -0.53% 440K
|
Health Technology
|
| O: 0.48%
H: 1.36%
C: 0.99%
XERS | $1.74 -2.25% 150K
|
Health Technology
|
| O: 7.18%
H: 4.52%
C: -4.07%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: 0.88%
H: 0.74%
C: 0.5%
OTIC | $0.077
|
Health Technology
|
| O: -0.84%
H: 5.93%
C: 0.42%
OMER | $3.09 38K
|
Health Technology
|
| O: 0.95%
H: 2.0%
C: 0.25%
GILD | $66.85 -0.27% 1M
|
Health Technology
|
| O: 0.09%
H: 2.4%
C: 1.6%
BCRX | News | $4.35 -0.69% 460K
|
Health Technology
|
| O: 0.82%
H: 2.39%
C: -1.11%
AMGN | News | $273.905 0.13% 270K
|
Health Technology
|
| O: 0.46%
H: 1.42%
C: 0.67%
$ 63.41 Billion growth in Monoclonal Antibodies Market 2021-2025 | Targeted therapeutic mechanism of action to boost growth | Technavio
Published: 2021-06-09 (Crawled : 06:00) - prnewswire.com
NVS | News | $98.03 0.77% 650K
|
Health Technology
|
| O: 1.91%
H: 0.96%
C: 0.9%
JNJ | News | $147.885 -1.12% 1.5M
|
Health Technology
|
| O: 0.37%
H: 1.09%
C: 0.98%
GSK | News | $40.82 -1.02% 230K
|
Health Technology
|
| O: 1.24%
H: 0.64%
C: 0.64%
ABBV | News | $168.635 -0.53% 440K
|
Health Technology
|
| O: 0.48%
H: 1.36%
C: 0.99%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: 0.88%
H: 0.74%
C: 0.5%
AZN | News | $70.905 0.08% 1.6M
|
Health Technology
|
| O: 1.15%
H: 1.22%
C: 1.12%
monoclonal antibodies growth antibody
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
CZOO | $11.44 129.26% 4.6M
|
AMST | $3.4 70.0% 51M
|
Technology Services
BOF | $1.78 52.14% 15M
|
SYRA | $1.5 51.23% 1M
|
n/a
CSSE 4 | $0.23 51.02% 46M
|
Consumer Services
RILY | $30.87 42.13% 7.8M
|
Finance
LICN | $0.76 35.71% 6.2M
|
TROO | $1.41 29.36% 280K
|
Manufacturing
MULN | News | $3.53 29.3% 4.8M
|
Information
RBBN 4 | $3.26 26.85% 1.2M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.